Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

B cell response to Anti-IgM and terbutaline treatment

ABSTRACT: Temporal analysis (60, 180, 360 min) of B cells treated with Anti-IgM alone, terbutaline alone or Anti-IgM and terbutaline (all in triplicates). Keywords: other

ORGANISM(S): Mus musculus

PROVIDER: GSE1021 | GEO | 2004/02/13

SECONDARY ACCESSION(S): PRJNA90259

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

B cell response to Anti-IgM and ELC treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with Anti-IgM alone, ELC alone or Anti-IgM and ELC (all in triplicates). Keywords: other

2004-02-13 | GSE1020 | GEO

B cell response to Anti-IgM and CD40 treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with Anti-IgM alone, CD40 alone or Anti-IgM and CD40 (all in triplicates). Keywords: other

2004-02-13 | GSE1019 | GEO

B cell response to CD40, Anti-IgM, ELC, IL4, terbutaline and lipopolysaccharide treatment

2004-02-16 | GSE1014 | GEO

B cell response to CD40, Anti-IgM, ELC, IL4, terbutaline and lipopolysaccharide treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with either: CD40 Anti-IgM ELC IL4 Lipopolysaccharide Terbutaline CD40 and IL4 CD40 and Lipopolysaccharide CD40 and Anti-IgM Anti-IgM and ELC Anti-IgM and Terbutaline ELC and Lipopolysaccharide This SuperSeries is composed of the following subset Series: GSE1019: B cell response to Anti-IgM and CD40 treatment GSE1020: B cell response to Anti-IgM and ELC treatment GSE1021: B cell response to Anti-IgM and terbutaline treatment GSE1022: B cell response to CD40 and lipopolysaccharide treatment GSE1023: B cell response to CD40 and IL4 treatment GSE1024: B cell response to ELC and lipopolysaccharide treatment Refer to individual Series

2010-06-09 | E-GEOD-1014 | biostudies-arrayexpress

B cell response to ELC and lipopolysaccharide treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with ELC alone, lipopolysaccharide alone or ELC and lipopolysaccharide (all in triplicates). Keywords: other

2004-02-13 | GSE1024 | GEO

B cell response to CD40 and IL4 treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with CD40 alone, IL4 alone or CD40 and IL4 (all in triplicates). Keywords: other

2004-02-13 | GSE1023 | GEO

B cell response to CD40 and lipopolysaccharide treatment

Project description:Temporal analysis (60, 180, 360 min) of B cells treated with CD40 alone, lipopolysaccharide alone or CD40 and lipopolysaccharide (all in triplicates). Keywords: other

2004-02-13 | GSE1022 | GEO

Transcription profiling of mouse CH1 B-cells upon stimulation either with anti-IgM, IL-4 or with a combination of anti-IgM and IL-4

Project description:We have studied CH1 cells that undergo G1 arrest upon anti-IgM treatment after 16 hrs of stimulation. First we studied the differential gene expression under anti-IgM and IL-4 stimulation condition individually and in combination, and this revealed the affected genes to be directly or indirectly playing a role for arresting the cells in the G1 phase of the cell cycle. We then performed Western blotting experiments for the selected signaling molecule candidates from various pathways, and the phosphorylation kinetic profiles were used to study their role in regulating the gene expression under anti-IgM and/or IL-4 stimulus. Finally, we profiled how the signaling pathways are regulating the activation and deactivation of 345 transcription factors, which are responsible for regulating the anti-IgM and/or IL-4 responsive genes, which in turn leads to the functional output.

2010-01-19 | E-MTAB-82 | biostudies-arrayexpress

Gene expression in anti-IgM IFNg treated B cells

Project description:RNAseq data of human naive B cells untreated or stimulated with anti-IgM and IFNg

2021-08-11 | GSE181739 | GEO

WT and Ikaros-deficient follicular B cells stimulated with anti-IgM

Project description:We have observed that follicular B cells from mice with a hypomorphic mutation (IkL/L) in the Ikzf1 gene (which encodes the Ikaros transcription factor) exhibit an increased proliferative response to anti-IgM stimulation (Kirstetter et al, Eur J Immunol, 32:720-30, 2002). We asked if Ikaros controls the transcriptional response that unfolds after activation, or if differences in the transcriptional landscape of resting B cells could explain the altered response. To this end, we have determined the transcriptome of unstimulated WT and IkL/L follicular B cells, as well as that of cells stimulated for 3h and 12h with anti-IgM. Samples from 2 independent experients were analyzed. Follicular splenic B cell were sorted from 6-week old WT or IkL/L mice, and stimulated for 3 or 12h with anti IgM, or cultured without anti-IgM for 3h (unstimulated samples) 2 independant experiments were performed

2016-01-26 | E-GEOD-75712 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data